Azithromycin dosage cat scratch disease emedicine

Alibek K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world. New York: Random House, 1999

APHIS (Animal and Plant Health Inspection Service). National Animal Health Reporting System [Web page]

APHL (Association of Public Health Laboratories). State public health laboratories emergency contact directory. 2013 Apr [Full text]

Ashdown LR. An improved screening technique for isolation of Pseudomonas pseudomallei from clinical specimens. Pathology 1979 Apr;11(2):293-7 [Abstract]

ASM (American Society for Microbiology). Sentinel laboratory guidelines for suspected agents of bioterrorism: clinical laboratory bioterrorism readiness plan. 2006 Aug 10 [Full text]

ASM. Sentinel laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases: packing and shipping infectious substances. 2012 Dec 20 [Full text]

ASM. Sentinel level clinical microbiology laboratory guidelines [Web page]

ASM. Sentinel level clinical microbiology laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases: Burkholderia mallei and B pseudomallei. 2013 Jul

Baker A, Tahani D, Gardiner C, et al. Groundwater seeps facilitate exposure to Burkholderia pseudomallei. Appl Environ Microbiol 2011;77(20):7243-6 [Abstract]

Bartlett JG. Glanders. In: Gorbach SL, Barlett JG, Blacklow NR. Infectious diseases. Ed 3. Philadelphia, PA: Lippincott Williams & Wilkins, 2004:1463-4

Batmanov VP, Ilyukhin VI, Lozovaya NA, et al. Urgent prophylaxis of experimental melioidosis in white rats [Abstract no. 61]. In: Programs and abstracts book of the 2004 ASM Biodefense Research Meeting, Baltimore, MD. Washington, DC: ASM, 2004:31

Bossi P, Tegnell A, Baka A, et al. Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis. Euro Surveill 2004 Dec 15;9(12):e17-8 [Full text]

Brodie EL, DeSantis TZ, Moberg Parker JP, et al. Urban aerosols harbor diverse and dynamic bacterial populations. Proc Natl Acad Sci 2007 Jan 2;104(1):299-304 [Full text]

Burivong W, Wu X, Saenkote W, Stern EJ. Thoracic radiologic manifestations of melioidosis. Curr Probl Diagn Radiol 2012;41(6):199-209 [Abstract]

CDC (Centers for Disease Control and Prevention). Biosafety in microbiological and biomedical laboratories (BMBL). Ed 5. Dec 2009 [Web page with link to full text]

CDC. Select Agents and Toxins [Web page]

CDC. Facts about the Laboratory Response Network [Full text]

CDC. Glanders. 2012 Jan 13 [Full text]

CDC. Laboratory-acquired human glanders—Maryland, May 2000. MMWR 2000 Jun 23;49(24):532-5 [Full text]

CDC. Laboratory exposure to Burkholderia pseudomallei—Los Angeles, California, 2003. MMWR 2004 Oct 29;53(42):988-90 [Full text]

CDC. Laboratory Response Network [PowerPoint presentation]

CDC. Laboratory security and emergency response guidance for laboratories working with select agents. MMWR 2002 Dec 6;51(RR19):1-8 [Full text]

CDC. Medical examiners, coroners, and biologic terrorism: a guidebook for surveillance and case management. MMWR 2004 Jun 11;53(RR8):1-27 [Full text]

CDC. Melioidosis. 2012 Jan 26 [Full text]

CDC. Public Health Image Library [Web page]

CDC. Recognition of illness associated with the intentional release of a biologic agent. MMWR 2001 Oct 19;50(41):893-7 [Full text]

CDC/APHIS. HHS and USDA select agents and toxins. 7 CFR part 331, 9 CFR part 121, and 42 CFR part 73. 2008 Nov 17 [Web page]

CDC/HICPAC (Healthcare Infection Control Practices Advisory Committee). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. [Web page with link to full text]

CFSPH (Center for Food Security and Public Health, Iowa State University). Glanders. 2007 Aug 31 [Full text]

CFSPH. Melioidosis. 2007 Nov 30 [Full text]

Chantratita N, Rholl DA, Sim B, et al. Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei. Proc Natl Acad Sci 2011;108(41):17165-70 [Abstract]

Cheng AC, Currie BJ, Dance DAB, et al. Clinical definitions of melioidosis. Am J Trop Med Hyg 2013 Mar;88(3):411-3 [Full text]

Cheng AC, Dance DA, Currie BJ. Bioterrorism, glanders and melioidosis. Euro Surveill 2005 Mar;10(3):e1-2 [Full text]

Cheng AC, O'Brien M, Freeman K, et al. Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg 2006 Feb;74(2):330-4 [Full text]

Croddy E, Perez-Armedariz C, Hart J. Glanders. In: Croddy E, Perez-Armedariz C, Hart J. Chemical and biological warfare: a comprehensive survey for the concerned citizen. New York, NY: Springer-Verlag, 2002:207-8

Currie BJ. Burkholderia pseudomallei and Burkholderia mallei: melioidosis and glanders. In: Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. Ed 7. Philadelphia, PA: Elsevier Churchill Livingstone, 2010;2:2869-78

Dai D, Chen YS, Chen PS, et al. Case cluster shifting and contaminant source as determinants of melioidosis in Taiwan. Trop Med Int Health 2012 Aug;17(8):1005-13 [Abstract]

Dance DA, Davis TM, Wattanagoon Y, et al. Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis 1989 Apr;159(4):654-60 [Abstract] 

Derbyshire JB. The eradication of glanders in Canada. Can Vet J 2002 Sep;43(9):722-6 [Full text]

Dvorak GD, Spickler AR. Glanders.J Am Vet Med Assoc 2008 Aug 15;233(4):570-7 [Full text]

Francis A, Aiyar S, Yean CY, et al. An improved selective and differential medium for the isolation of Burkholderia pseudomallei from clinical specimens. Diagn Microbiol Infect Dis 2006 Jun;55(2):95-9 [Abstract]

Galyov EE, Brett PJ, DeShazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol 2010 Oct 13;64:495-517 [Abstract]

Gelhaus HC, Anderson MS, Fisher DA, et al. Efficacy of postexposure administration of doxycycline in a murine model of inhalational melioidosis. Sci Rep 2013 Jan;3:1146 [Full text]

Georgiades C, Fishman EK. Glanders disease of the liver and spleen: CT evaluation. J Comput Assist Tomogr 2001 Jan-Feb;25(1):91-3 [Full text]

Gilad J, Harary I, Dushnitsky T, et al. Burkholderia mallei and Burkholderia pseudomallei as bioterrorism agents: national aspects of emergency preparedness. Isr Med Assoc J 2007 Jul;9(7):499-503 [Full text]

Gilbert RO. Glanders.In: Foreign animal diseases: the gray book. Ed 7. St Joseph, MO: US Animal Health Association, 2008:281-6 [Full text]

Gilligan PH, Lum G, Vandamme PA, et al. Burkholderia, Stenotrophomonas, Ralstonia, Brevundimonas, Comamonas, Delftia, Pandoraea, and Acidovarox. In: Murray PR, Baron EJ, Jorgensen JH, et al. Manual of clinical microbiology. Ed 8. Vol 1. Washington, DC: ASM Press, 2003:729-48

Glass MB, Gee JE, Steigerwalt AG, et al. Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 2006 Dec;44(12):4601-4 [Full text]

Glass MB, Popovic T. Preliminary evaluation of the API 20NE and RapID NF Plus systems for rapid identification of Burkholderia pseudomallei and B mallei. J Clin Microbiol 2005 Jan;43(1):479-83 [Full text]

Gregory BC, Waag DM. Glanders. In: Dembek ZF, ed. Textbooks of military medicine: medical aspects of biological warfare. Washington, DC: Borden Institute, 2007:121-46 [Full text]

Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968 Apr;44(4):599-605 [Abstract]

Hampton V, Kaestli M, Mayo M, Choy JL. Melioidosis in birds and burkholderia pseudomallei dispersal, Australia. Emerg Infect Dis 2011;17(7):1310-2 [Full text]

Harris S. The Japanese biological warfare programme: an overview. In: Geissler E, van Courtland Moon JE, eds. Biological and toxin weapons: research, development and use from the Middle Ages to 1945. London: Oxford University Press, 1999:127-52

Hayden HS, Lim R, Brittnacher MJ, et al. Evolution of Burkholderia pseudomallei in recurrent melioidosis. PLoS One 2012;7(5):e36507 [Full text]

Heine HS, England MJ, Waag DM, et al. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother 2001 Jul;45(7):2119-21 [Full text]

HHS (Department of Health and Human Services). Possession, use, and transfer of select agents and toxins: final rule. 42 CFR parts 72 and 73. Fed Reg 2005 Mar 18;70(52):13294-325 [Full text]

Holden MT, Titball RW, Peacock SJ, et al. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci 2004 Sep 28;101(39):14240-5 [Full text]

Howe C, Miller WR. Human glanders: report of six cases. Ann Intern Med 1947 Jan 1;26(1):93-115

HPA (Health Protection Agency, UK). Guidelines for action in the event of a deliberate release of glanders and melioidosis. Version 3.3. 2008 Oct 30 [Full text]

IATA (International Air Transport Association). Infectious substances shipping guidelines. In: Dangerous goods regulations—2010. Ed 51. International Air Transport Association, 2009 Sep 21

Kaestli M, Richardson LJ, Colman RE, et al. Comparison of TaqMan PCR assays for detection of the melioidosis agent Burkholderia pseudomallei in clinical specimens. J Clin Microbiol 2012;50(6):2059-62 [Abstract]

Kasten FH. Biological weapons, war crimes, and WWI. Science 2002 May 17;296(5571):1235-7

Kenny DJ, Russell azithromycin dosage cat scratch disease emedicine P, Rodgers D, et al. In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob Agents Chemother 1999 Nov;43(11):2773-5 [Full text]

Khan AS, Swerdlow DL, Juranek, DD. Precautions against biological and chemical terrorism directed at food and water supplies. Public Health Rep 2001 Jan-Feb;116(1):3-14 [Full text]

Kung C-T, Li C-J, Hung S-C, et al. Acute melioid community-acquired pneumonia. Int J Infect Dis 2011;15(9):e627-30 [Abstract]

Kung CT, Li CJ, Ko SF, et al. A melioidosis patient presenting with brainstem signs in the emergency department. J Emerg Med 2013 Jan;44(1):e9-12 [Abstract]

Larsen JC, Johnson NH. Pathogenesis of Burkholderia pseudomallei and Burkholderia mallei. Mil Med 2009 Jun;174(6):647-51 [Abstract]

Limmathurotsakul D, Kanoksil M, Wuthiekanun V, et al. Activities of daily living associated with acquisition of melioidosis in northeast Thailand: a matched case-control study. PLoS Negl Trop Dis 2013 Jan;7(2):e2072 [Full text]

Limmathurotsakul D, Thammasart S, Warrasuth N, et al. Melioidosis in Animals, Thailand, 2006–2010. Emerg Infect Dis 2012;18(2):325-7 [Full text]

Lipsitz R, Garges S, Aurigemma R, et al. Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010. Emerg Infect Dis 2012 (published online Nov 5) [Full text]

Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002 Dec;40(12):4625-7 [Full text]

Martin JW, Christopher GW, Eitzen EM Jr. History of biological weapons: from poisoned darts to intentional epidemics. In: Dembek ZF, ed. Textbooks of military medicine: medical aspects of biological warfare. Washington, DC: Borden Institute, 2007:1-20 [Full text]

Maude RR, Vatcharapreechasakul T, Ariyaprasert P, et al. Prospective observational study of the frequency and features of intra-abdominal abscesses in patients with melioidosis in northeast Thailand. Trans R Soc Trop Med Hyg 2012 Oct;106(10):629-31 [Abstract]

Nandasiri S, Wimalaratna H, Manjula M, Corea E. Transverse myelitis secondary to melioidosis: a case report. BMC Infect Dis 2012 Jan;12:232 [Full text]

NCBI (National Center for Biotechnology Information). GenBank overview. [Web page]

Nierman WC, DeShazer D, Kim HS, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci 2004 Sep 28;101(39):14246-51 [Full text]

O'Hara CM. Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. Clin Microbiol Rev 2005 Jan;18(1):147-62 [Full text]

OIE (Office International des Epizooties [World Organization for Animal Health]). Glanders. In: OIE. Manual of diagnostic tests and vaccines for terrestrial animals. 2010 [Full text]

OIE. WAHID (World Animal Health Information Database) [Web page]

Pappas G, Panagopoulou P, Christou L, et al. Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogens. Infect Dis Clin North Am 2006 Jun;20(2):395-421

Parameswaran U, Baird RW, Ward LM, et al. Melioidosis at Royal Darwin Hospital in the big 2009–2010 wet season: comparison with the preceding 20 years. Med J Aus 2012;196(5):345-8 [Full text]

Peacock SJ, Chieng G, Cheng AC, et al. Comparison of Ashdown’s medium, Burkholderia cepacia medium, and Burkholderia pseudomallei selective agar for clinical isolation of Burkholderia pseudomallei. J Clin Microbiol 2005 Oct;43(10):5359–61 [Full text]

Peacock SJ, Limmathurotsakul D, Lubell Y, et al. Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes. PLoS Negl Trop Dis 2012;6(1):e1488 [Full text]

Peacock SJ, Schweizer HP, Dance DAB, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B mallei. Emerg Infect Dis 2008 Jul;14(7):e2 [Full text]

Price EP, Dale JL, Cook JM, et al. Development and validation of Burkholderia pseudomallei-specific real-time PCR assays for clinical, environmental or forensic detection applications. PLoS One 2012;7(5):e37723 [Full text]

Pumpuang A, Chantratita N, Wikraipat C. Survival of Burkholderia pseudomallei in distilled water for 16 years. Trans R Soc Trop Med Hyg 2011 Oct;105(10):598-600 [Abstract]

Rabinowitz P, Gordon Z, Chudnov D, et al. Animals as sentinels of bioterrorism agents. Emerg Infect Dis 2006 Apr;12(4):647-52 [Abstract]

Rammaert B, Beauté J, Borand L, et al. Pulmonary melioidosis in Cambodia: a prospective study. BMC infect Dis 2011;11(1):126 [Full text]

Rega PP. CBRNE—Glanders and melioidosis. eMedicine 2009 Mar 3 [Full text]

Rosenbloom M, Leikin JB, Vogel SN, et al. Biological and chemical agents: a brief synopsis. Am J Ther 2002 Jan-Feb;9(1):5-14 [Abstract]

Rowland CA, Lertmemongkolchai G, Bancroft A, et al. Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei. Infect Immun 2006 Sep;74(9):5333-40 [Full text]

Rusnak JM, Kortepeter MG, Aldis J, et al. Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). J Occup Environ Med 2004 Aug;46(8):801-11 [Abstract]

Salam A, Khan N, Malnick H, et al. Melioidosis acquired by traveler to Nigeria. Emerg Infect Dis 2011;17(7):1296-8 [Full text]

Schlech WF 3rd, Turchik JB, Westlake RE Jr, et al. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981 Nov 5;305 (19):1133-5

Scholz HC, Joseph M, Tomaso JM, et al. Detection of the reemerging agent Burkholderia mallei in a recent outbreak of glanders in the United Arab Emirates by a newly developed fliP-based polymerase chain reaction assay. Diagn Microbiol Infect Dis 2006 Apr;54(4):241-7 [Abstract]

Sermswan RW, Wongratanacheewin S, Anuntagool N, et al. Comparison of the polymerase chain reaction and serologic tests for diagnosis of septicemic melioidosis. Am J Trop Med Hyg 2000 Sep-Oct;63(3-4):146-9 [Full text]

Sewell DL. Laboratory safety practices associated with potential agents of biocrime or bioterrorism. J Clin Microbiol 2003 Jul;41(7):2801-9 [Full text]

Srinivasan A, Kraus CN, DeShazer D, et al. Glanders in a military research microbiologist. N Engl J Med 2001 Jul 26;345(4):256-8 [Full text]

Stewart T, Engelthaler DM, Blaney DD, et al. Epidemiology and investigation of melioidosis, southern Arizona. Emerg Infect Dis 2011;17(7):1286-8 [Full text]

Thatrimontrichai A, Maneenil G. Neonatal melioidosis: systematic review of the literature. Pediatr Infect Dis J 2012 Nov;31(11):1195-7 [Abstract]

Thibault FM, Hernandez E, Vidal DR, et al. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 2004 Dec;54(6):1134-8 [Full text]

Tiyawisutsri R, Peacock SJ, Langa S, et al. Antibodies from patients with melioidosis recognize Burkholderia mallei but not Burkholderia thailandensis antigens in the indirect hemagglutinin assay. J Clin Microbiol 2005 Sep;43(9):4872-4 [Full text]

Tolaney P, Lutwick LI. Melioidosis. In: Lutwick LI, Lutwick SM, eds. Beyond anthrax: the weaponization of infectious diseases. Towata, NJ: Humana Press, 2009:145-58

Tuanyok A, Stone JK, Mayo M, et al. The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl Trop Dis 2012;6(1):e1453 [Abstract]

USAMRIID (US Army Medical Research Institute of Infectious Diseases). USAMRIID's medical management of biological casualties handbook. Ed 7. Fort Detrick Frederick, MD: USAMRIID, 2011 Sep [Full text]

van der Geest P, van der Jagt M, van Thiel R, et al. Acute respiratory distress syndrome with refractory hypoxaemia and severe septic shock caused by melioidosis: successful treatment with veno-venous extracorporeal membrane oxygenation. Anaesth Intensive Care 2013;41(2):262–3 [Abstract]

Vidyalakshmi K, Lipika S, Vishal S, et al. Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India. Int J Infect Dis 2012 Jul;16(7):e491-7 [Abstract]

Vietri NJ, Deshazer D. Melioidosis. In: Dembek ZF, ed. Textbooks of military medicine: medical aspects of biological warfare. Washington, DC: Borden Institute, 2007:121-46 [Full text]

Vlieghe E, Kruy L, De Smet B, et al. Melioidosis, Phnom Penh, Cambodia. Emerg Infect Dis 2011;17(7):1289-92 [Full text]

Waag DM, DeShazer D. Glanders: new insights into an old disease. In: Lindler LE, Lebeda FJ, Korch GW, eds. Biological weapons defense: infectious disease and counterbioterrorism. Totowa, NJ: Humana Press, 2005:209-37

Weissert C, Dollenmaier G, Rafeiner P, et al. Burkholderia pseudomallei misidentified by automated system. Emerg Infect Dis 2009 Nov; 15(11):1799-801 [Full text]

Wheelis M. First shots fired in biological warfare. Nature 1998 Sep 17;395(6699):213 [Full text]

WHO (World Health Organization). Public health response to biological and chemical weapons: WHO guidance. Ed 2. Annex 3 Biological agents, 2004:246-50 [Full text]

Wiersinga WJ, van der Poll T, White NJ, et al. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 2006 Apr;4(4):272-82 [Abstract]

Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012;367(11):1035–44

Wuthiekanun V, Amornchai P, Saiprom N, et al. Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in northeast Thailand. Antimicrob Agents Chemother 2011;55(11):5388-91 [Abstract]

Back to top




Dysbiosis - Bacterial, Fungal Parasitic Overgrowth Harga zithromax for strep

Azithromycin dosage cat scratch disease emedicine Kr
Azithromycin dosage cat scratch disease emedicine Antiretroviral Contraindications and Drug Interactions
Azithromycin dosage cat scratch disease emedicine Azithromycin - t
Azithromycin dosage cat scratch disease emedicine Azithromycin Oral : Uses, Side Effects. - WebMD
Azithromycin dosage cat scratch disease emedicine Bacterial Urinary Tract Infections (UTIs) - Genitourinary
Azithromycin dosage cat scratch disease emedicine Best prices for medications

Дата: 05.09.2017, 20:04 / Просмотров: 83462